4th Quarter - Report

WILLIAMS AND JENSEN, PLLC for SANOFI, U.S.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Policies impacting vaccine access, disease prevention programs, and prescription drug labeling requirements.

LobbyistCovered position, as disclosed
JEANNE HAGGERTY Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
KURT SCHRADER Former Member of Congress

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

LobbyistCovered position, as disclosed
JEANNE HAGGERTY Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KURT SCHRADER Former Member of Congress

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (119th)

Medical/Disease Research/Clinical Labs MED

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.

LobbyistCovered position, as disclosed
JEANNE HAGGERTY Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
SUSAN HIRSCHMANN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals. 340B, Vaccine issues.

LobbyistCovered position, as disclosed
ROBERT BUTORA New Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess
JEANNE HAGGERTY Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
CHRISTOPHER W HATCHER —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KURT SCHRADER Former Member of Congress
CHRISTOPHER E. WILCOX LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Monitor general tax issues related to international tax, vaccine excise taxes and orphan drug tax issues; implementation of PL 119-21.

LobbyistCovered position, as disclosed
JEANNE HAGGERTY Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
CHRISTOPHER W HATCHER —
CHRISTOPHER E. WILCOX LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.